GlaxoSmithKline celebrates its role in supporting the biggest anti-doping operation in the history of the Olympic Games
16 July 2012 | By GlaxoSmithKline
GSK launches new advertising campaign...
List view / Grid view
News
U.S. FDA approves Gilead ’s Truvada® for reducing the risk of acquiring HIV
16 July 2012 | By Gilead Sciences
The U.S. FDA has approved once-daily oral Truvada®...
Ilka Diester wins Boehringer Ingelheim’s FENS Award 2012 for Exceptional Research in Neuroscience
16 July 2012 | By Boehringer Ingelheim
This year's Boehringer Ingelheim FENS Award was granted to Ilka Diester...
The Abbott Fund announces $1 million partnership with the Secretary’s International Fund for Women and Girls
16 July 2012 | By Abbott
The Abbott Fund announces $1 million partnership...
Merck highlights data presentations at the Alzheimer’s Association International Conference 2012
13 July 2012 | By Merck
Merck announced presentations at the upcoming AAI Conference...
Abbott focuses on the importance of information management and automation at the AACC Lab Expo
Abbott will feature new solutions to improve data management and automation at this year’s American Association for Clinical Chemistry (AACC) annual meeting, July 15-19, in Los Angeles, Calif. Solutions to further enhance efficiency and workflow in today’s laboratories will be the focal point of the Abbott exhibit.
GSK and Theravance announce regulatory submissions for FF/VI in the US and Europe
13 July 2012 | By GlaxoSmithKline
Relvar™ and Breo™ proposed as brand names for FF/VI in EU and US...
Daiichi Sankyo to build production facilities for biopharmaceuticals
12 July 2012 | By Daiichi Sankyo
Daiichi Sankyo has been approved for the Japanese Ministry of Economy, Trade and Industry’s production facility building grant...
US Regulatory Update – Tykerb® (lapatinib)
12 July 2012 | By GlaxoSmithKline
GlaxoSmithKline has withdrawn a supplemental New Drug Application to the US FDA for Tykerb...
Update on Phase III trial for Odanacatib, Merck’s investigational cat-K inhibitor for Osteoporosis
11 July 2012 | By Merck
Merck announced an update on the Phase III trial...
GSK announces positive data from Harmony 8 and completion of clinical registration package for albiglutide
11 July 2012 | By GlaxoSmithKline
Data has been received from the Phase III Harmony 8 study...
Lilly announces Pomaglumetad Methionil did not meet primary endpoint of clinical study
11 July 2012 | By Eli Lilly and Company
Eli Lilly and Company announced negative clinical trial results...
Abbott introduces OneLab, a novel integrated Web-based software platform
As health care systems around the world face challenges such as labor shortages, increased regulation and budget constraints, they rely on technology to help manage the impact. To assist in addressing these challenges, today Abbott announced OneLab, a new, Web-based, integrated laboratory informatics solution.
Recent advances in controlled release, solubility, and ODT applications presented by Catalent expert
Michael J. Valazza R.Ph., Vice President, Global Modified Release Technologies, Catalent Pharma Solutions, will be presenting on “Recent Advances in Oral Granules and Fixed Dose Tablet technologies, OptiMeltTM Solubility Enhancement Solutions, and Oral Disintegrating Tablet applications,” on Sunday, July 15th from 10:15AM -11:15AM as part of a releasing technology workshop…
Shionogi-ViiV Healthcare announces positive initial data from phase III study of dolutegravir-based regimen vs Atripla in HIV
11 July 2012 | By GlaxoSmithKline
Phase III SINGLE study results...
